Note*: This report requires 7-10 business days to complete.
DelveInsight’s Anal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Anal Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Anal Cancer till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Anal Cancer market.
• Identifying patient populations in the global “Anal Cancermarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Anal Cancer therapeutics in each of the markets covered.
• To understand the future market competition in the global Anal Cancer therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Anal Cancer for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Anal Cancer overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Anal Cancer Market
• Global Epidemiology of Anal Cancer Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Anal Cancer Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Anal Cancer (2013-2023)
• Table 7: Anal Cancer Global Market (USD Millions), (2013-2015)
• Table 8: Anal Cancer Global Market (USD Millions), (2016-2023)
• Table 9: Anal Cancer US Market (USD Millions), (2013-2015)
• Table 10: Anal Cancer US Market (USD Millions), (2016-2023)
• Table 11: Anal Cancer Germany Market (USD Millions), (2013-2015)
• Table 12: Anal Cancer Germany Market (USD Millions), (2016-2023)
• Table 13: Anal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Anal Cancer United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Anal Cancer France Market (USD Millions), (2013-2015)
• Table 16: Anal Cancer France Market (USD Millions), (2016-2023)
• Table 17: Anal Cancer Italy Market (USD Millions), (2013-2015)
• Table 18: Anal Cancer Italy Market (USD Millions), (2016-2023)
• Table 19: Anal Cancer Spain Market (USD Millions), (2013-2015)
• Table 20: Anal Cancer Spain Market (USD Millions), (2016-2023)
• Table 21: Anal Cancer Japan Market (USD Millions), (2013-2015)
• Table 22: Anal Cancer Japan Market (USD Millions), (2016-2023)
• Table 23: Anal Cancer ROW Market (USD Millions), (2013-2015)
• Table 24: Anal Cancer ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Anal Cancer Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Anal Cancer (2013-2023)
• Figure 3: Anal Cancer Global Market (USD Millions), (2013-2015)
• Figure 4: Anal Cancer Global Market (USD Millions), (2016-2023)
• Figure 5: Anal Cancer US Market (USD Millions), (2013-2015)
• Figure 6: Anal Cancer US Market (USD Millions), (2016-2023)
• Figure 7: Anal Cancer Germany Market (USD Millions), (2013-2015)
• Figure 8: Anal Cancer Germany Market (USD Millions), (2016-2023)
• Figure 9: Anal Cancer United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Anal Ca+M76ncer United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Anal Cancer France Market (USD Millions), (2013-2015)
• Figure 12: Anal Cancer France Market (USD Millions), (2016-2023)
• Figure 13: Anal Cancer Italy Market (USD Millions), (2013-2015)
• Figure 14: Anal Cancer Italy Market (USD Millions), (2016-2023)
• Figure 15: Anal Cancer Spain Market (USD Millions), (2013-2015)
• Figure 16: Anal Cancer Spain Market (USD Millions), (2016-2023)
• Figure 17: Anal Cancer Japan Market (USD Millions), (2013-2015)
• Figure 18: Anal Cancer Japan Market (USD Millions), (2015-2023)
• Figure 19: Anal Cancer ROW Market (USD Millions), (2013-2015)
• Figure 20: Anal Cancer ROW Market (USD Millions), (2016-2023)
• Advaxis Inc.
• Amgen Inc.
• Eli Lilly and Company
• Genticel S.A.
• ISA Pharmaceuticals B.V.
• Novartis AG
• Oryx GmbH & Co. KG
• PDS Biotechnology Corporation
• Sun Pharma Advanced Research Company Ltd.
• Taiwan Liposome Company Ltd.
